Excellergy
Phase 3Trailblazing the first trifunctional Effector Cell Response Inhibitors (ECRIs) to deliver what existing therapies cannot: rapid and complete control of allergic responses.
Founded
2013
Employees
11-50
Focus
AI / Machine LearningDrug Delivery
About
Trailblazing the first trifunctional Effector Cell Response Inhibitors (ECRIs) to deliver what existing therapies cannot: rapid and complete control of allergic responses.
Company Info
TypePrivate
Founded2013
Employees11-50
LocationSan Francisco, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile